Sue Wallace

Sue Wallace has been active in the Wisconsin biohealth community for over 30 years.  Her work in the radiation sciences community has helped transform Positron Emission Tomography (PET)  imaging from a cutting-edge research tool into a cornerstone of modern medicine, and today she continues to push the boundaries of what’s possible in the fight against cancer.

While earning a PhD in radiopharmaceutical chemistry she was captivated by the remarkable ability of PET radiopharmaceuticals to provide a vivid, real-time view of molecular activity and the profound impact it could have on understanding and treating complex diseases.

Dr. Wallace began her commercial career at GE Healthcare where the seeds of innovation were sown to revolutionize cancer diagnosis and treatment using the power of molecular imaging.   As the demand for PET scanners grew nationwide, she joined Cardinal Health with the mission of establishing a comprehensive network of radiopharmaceutical production facilities. This initiative was crucial in ensuring that high-quality radiopharmaceuticals were available coast to coast, making PET imaging accessible across the entire country.

As the ability to detect disease matured, Dr. Wallace moved to Philips’ Radiation Oncology to focus on precision treatment planning technologies that enhance the effectiveness of cancer treatments worldwide.  And today, as the CEO of Voximetry, she is changing the Standard of Care for late-stage cancer patients by creating treatment plans tailored for the individual.

Born in Racine, Wisconsin, Dr. Wallace is a GE trained Six Sigma Master Black Belt.  She holds a B.S. degree in Chemistry from the University of Wisconsin – Milwaukee, and a Master of Science in Nuclear Chemistry & Doctorate in Radiopharmaceutical Chemistry from Washington University in St. Louis.    As a single mother of two, she has led 3 global businesses and is now proud to be leading a spin-off venture from the University of Wisconsin Medical Physics department.